C. Colin

Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study.

H. Martin, Y. Chapleur, L. Richert, 2012, European journal of medicinal chemistry.

Cereblon Harnesses Myc-Dependent Bioenergetics and Activity of CD8+ T lymphocytes.

R. Gillies, J. Cleveland, J. Messina, 2020, Blood.

HDAC11 Deficiency or Inhibition Disrupts Oncogene-Induced Stress Hematopoiesis in Myeloproliferative Neoplasms.

R. Levine, A. Verma, K. Wright, 2019, Blood.

Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells.

G. Monard, M. Diederich, C. Cerella, 2018, International journal of oncology.

New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

Y. Chapleur, S. Flament, M. Boisbrun, 2010, Breast Cancer Research and Treatment.

Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2

D. Coppola, S. Chellappan, Xiaozhang Zheng, 2020, Scientific Reports.

Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2

D. Coppola, S. Chellappan, Xiaozhang Zheng, 2020, Scientific Reports.